Date: March 3 (Fri) 12:50-13:50
Anticoagulant Therapy for Sepsis-Induced DIC
Jerrold H Levy
（Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Duke University Medical Center, Durham, NC, USA）
Date: March 3 (Fri) 14:30-15:30
ICU Delirium Prevention and Treatment via a Multidisciplinary Approach
Dale M. Needham
（Pulmonary & Critical Care Medicine, and Physical Medicine & Rehabilitation, and Nursing, Johns Hopkins University, USA; Critical Care Physical Medicine & Rehabilitation Program, Johns Hopkins Hospital, USA）
Date: March 4 (Sat) 8:10-9:10
ECMO for COVID-19: A comprehensive review
Graeme MacLaren
（Director of Cardiothoracic ICU NATIONAL UNIVERSITY HOSPITAL, Singapore）
Date: March 3 (Fri) 15:40-16:10
Current topics for pediatric ECMO
Graeme MacLaren
（Cardiothoracic ICU, National University Hospital, Singapore）
Date: March 2 (Thu) 9:00-10:10
EngO-1 Post-intensive care syndrome worsens long-term prognosis in patients with sepsi
Shigeaki Inoue
(Dept. of Disaster and Emergency Medicine, School of Medicine, Kobe University）
EngO-2 A quality improvement initiative to reduce blood culture contamination at the emergency department
Mayu Hikone
（Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital）
EngO-3 Factors associated with Support Requirement by Medical Social Workers in Elderly Patients
Shunichiro Naka
（Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine）
EngO-4 Prehospital Advanced Life Support and ECPR: A Secondary Analysis of the SAVE-J II Study
Tetsuya Yumoto
（Department of Emergency, Critical Care, and Disaster Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University)
EngO-5 Changes in temperature management after out-of-hospital cardiac arrest between 2012 and 2017
Chie Tanaka
（Nippon medical school tamanagayama hospital）
EngO-6 Report on Drug Interactions with Paxlovid ®PACK for the Treatment of COVID-19
Michiya Akabane
（Department of Pharmacy, Shiga University of Medical Science Hospital）
EngO-7 Pregnant Patient with Severe COVID-19 Pneumonia Treated by Intensive Immune Suppression Therapy
Michika Hamada
（departent of acute critical care medicine, Juntendo University Shizuoka Hospital）
© 2022 The 50th Annual Meetings of
the Japanese Society of Intensive Care Medicine